Ardea Biosciences (RDEA) Lower Following Pricing of 8.5M Common Offering
Tweet
Share
E-mailGet Alerts RDEA Hot Sheet
Join SI Premium – FREE
Ardea Biosciences, Inc. (Nasdaq: RDEA) shares are over 5 percent lower early following pricing of its 8.5 million common stock offering. The firm priced the shares at $17 each, a discount of 6.5 to Tuesday's closing of $18.19.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karman Line Acquisition closes $200M IPO on Nasdaq
- Edesa Biotech prices $25M public offering on Nasdaq
- QTREX Quantum prices $10 million registered direct offering
Create E-mail Alert Related Categories
Equity Offerings, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
